Data / Form D filings / QMatter, Inc.
QMatter, Inc.: Form D filing
QMatter, Inc., a biotechnology company in London, United Kingdom, filed a Form D with the SEC in 2026. The latest, on April 9, 2026, reports $1.2 million sold of a $1.2 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10 SOUTH HILL PARK, FIRST FLOOR FLAT, London, United Kingdom, NW3 2
- Phone
- (617) 251-7707
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2128509
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | New notice | $1,182,889 | $1,182,889 | 4 | Mar 26, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alexis Ralli | Executive Officer, Director | |
| Blair Robertson | Director | |
| Owen Lozman | Director | |
| Timothy Weaving | Director |
Every Form D from the week of Apr 6, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what QMatter, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.